Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
06.12.2024 12:44:45

OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative

EssilorLuxottica
214.82 CHF 1.34%
Kaufen / Verkaufen

OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative 

Paris, France and Geneva, Switzerland (6 December 2024) – The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

The SPECS initiative builds on the world’s first-ever global target to increase effective refractive error coverage by 40% by 2030, which was endorsed by WHO Member States in 2021 at the World Health Assembly. 

This collaboration between WHO and the Foundation represents a significant step forward in addressing refractive error, preventing myopia, and improving access to vision care worldwide, particularly in low-resource settings. 

The collaboration will focus on knowledge sharing, technical input, and data provision to scale impactful solutions and ensure the effective implementation of United Nations’ ‘Vision for Everyone’ resolution. By leveraging their respective expertise, WHO and the Foundation aim to make sustainable vision care accessible to millions, improving health outcomes and social inclusion. 

Dr Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, emphasized the importance of collaborative action in achieving global eye health targets: "Vision care is not just a health priority – it is a social and economic imperative. The SPECS 2030 initiative, which underpins the UN ‘Vision for Everyone’ resolution, reminds us that effective collaboration can amplify impact, delivering tangible results for communities worldwide.

The WHO SPECS 2030 initiative accelerates global eye health efforts by focusing on five key pillars: Services, improving access to refractive services; Personnel, building the capacity of eye care professionals; Education, promoting public awareness about eye health; Cost, reducing the cost of eyeglasses and services; and Surveillance, strengthening data collection and research. 

Across these areas, the Foundation will provide technical input, share best practices, and contribute data to inform WHO’s initiatives in alignment with the global eye care target of effective refractive error coverage. 

Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, highlighted the transformative potential of the collaboration: "Uncorrected poor vision affects 2.7 billion people worldwide, posing a significant global challenge. As a result of the Foundation’s efforts, 961 million people in some of the most remote communities now have access to vision care services within a day’s travel, and 84 million pairs of eyeglasses have been provided to those in need. However, achieving the Foundation’s ambition of eliminating uncorrected poor vision in a generation will require collaborations that amplify impact. By uniting WHO’s leadership in public health with our expertise in delivering innovative, on-the-ground solutions, we believe we can create a multiplier effect to extend vision care to even the most underserved regions. Together, we have the power to transform lives and uplift entire communities.

This collaboration reflects a shared commitment to improving lives through better vision and advancing progress toward Sustainable Development Goals, especially in health, education, and economic participation.


From left to right: Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, and Dr. Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, formalize their collaboration under the WHO SPECS 2030 initiative. This collaboration marks a milestone effort to advance global vision care and expand access for underserved communities worldwide.

CONTACTS:

OneSight EssilorLuxottica Foundation
Mission & Foundation Communications
Marco Catalani, Lauren Wyper
media@essilorluxottica.com

About the OneSight EssilorLuxottica Foundation
The OneSight EssilorLuxottica Foundation is a registered charitable organization reflecting the commitment of EssilorLuxottica to eliminate uncorrected poor vision in a generation. It brings together EssilorLuxottica’s philanthropic, advocacy actions and investments. With nine regional affiliate offices, the Foundation has created sustainable access to vision care to millions of people in underserved communities around the world.https://onesight.essilorluxottica.com/

About The World Health Organization 
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int

Attachments


Analysen zu EssilorLuxottica

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
12.12.24 EssilorLuxottica Sector Perform RBC Capital Markets
12.12.24 EssilorLuxottica Buy Goldman Sachs Group Inc.
11.12.24 EssilorLuxottica Neutral UBS AG
03.12.24 EssilorLuxottica Neutral UBS AG
02.12.24 EssilorLuxottica Overweight JP Morgan Chase & Co.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Bitcoin: 150.000 USD Marke im 2025? | BX Swiss TV

Wird Bitcoin die 150.000 USD Marke nächstes Jahr erreichen und was heisst das kürzlich gesehen Allzeithoch für die Branche?

Im heutigen Experteninterview mit David Kunz, COO der BX Swiss spricht Sina Meier, Managing Director bei 2Shares über den Verlauf für Kryptowährungen des Jahres 2024.

Was dabei am besten lief, welche Auswirkungen institutionelle Anleger auf den Markt haben und welche neuen Innovationen man von 21Shares erwarten kann, erfahren Sie im heutigen Experteninterview.

👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!

Bitcoin: 150.000 USD Marke im 2025? | BX Swiss TV

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 11’841.99 19.27 BOFSVU
Short 12’050.00 13.20
Short 12’508.14 8.85 ZFSSMU
SMI-Kurs: 11’392.41 20.12.2024 17:30:00
Long 10’898.31 19.60 SSQMTU
Long 10’641.80 13.70 SSPM6U
Long 10’206.15 8.99 ARSSMU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten